Gushengtang (HKG:2273) attributable profit rose to 306.8 million yuan in 2024 from 252.2 million yuan in 2023.
Earnings per share at the traditional Chinese medicine manufacturer increased to 1.22 yuan from 1.03 yuan in the previous year, according to a Monday filing with the Hong Kong bourse.
Revenue grew 30% to 3.02 billion yuan from 2.32 billion yuan a year earlier.
The company declared a final dividend of HK$0.41 per share, payable July 11 to shareholders on record as of June 30.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。